Article
Bioactivation of Napabucasin Triggers Reactive Oxygen Species–Mediated Cancer Cell Death
16 Sept 2019
Abstract excerpt
Abstract Purpose: Napabucasin (2-acetylfuro-1,4-naphthoquinone or BBI-608) is a small molecule currently being clinically evaluated in various cancer types. It has mostly been recognized for its ability to inhibit STAT3 signaling. However, based on its chemical structure, we hypothesized that napabucasin is a substrate for intracellular oxidoreductases and therefore may exert its anticancer effect through redox...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
